Julien Barbier

12PUBLICATIONS
23CO-AUTHORS
Toxicology (incl. clinical toxicology)Infant and child healthCell development, proliferation and deathBiologically active moleculesBiomolecular modelling and design
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jun 21, 2024
Inhibition of OSBP blocks retrograde trafficking by inducing partial Golgi degradation.

Nianzhe He, Laura Depta, Cecilia Rossetti

|Jan 11, 2024
A New Derivative of Retro-2 Displays Antiviral Activity against Respiratory Syncytial Virus.

Adrien Le Rouzic, Jenna Fix, Robin Vinck

|May 26, 2023
Autophagic Degradation Is Involved in Cell Protection against Ricin Toxin.

Yu Wu, Clémence Taisne, Nassim Mahtal

|Dec 11, 2022
In Vivo Sustained Release of the Retrograde Transport Inhibitor Retro-2.1 Formulated in a Thermosensitive Hydrogel.

Robin Vinck, Laetitia Anvi Nguyen, Mathilde Munier

|Apr 12, 2022
Antiviral Effects of ABMA and DABMA against Influenza Virus In Vitro and In Vivo via Regulating the Endolysosomal Pathway and Autophagy.

Hongtao Liu, Chunlai Jiang, Yu Wu

|Jul 02, 2021
An adamantamine derivative as a drug candidate for the treatment of visceral leishmaniasis.

Sébastien Pomel, Sandrine Cojean, Valérie Pons

Pageof 2